Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biomedical Research | 4 | 2025 | 557 | 1.360 |
Why?
|
| Authorship | 1 | 2025 | 31 | 0.930 |
Why?
|
| Physicians, Women | 1 | 2025 | 52 | 0.900 |
Why?
|
| Publishing | 1 | 2025 | 115 | 0.860 |
Why?
|
| Surgeons | 3 | 2023 | 285 | 0.830 |
Why?
|
| Academic Success | 1 | 2023 | 23 | 0.800 |
Why?
|
| General Surgery | 1 | 2025 | 220 | 0.790 |
Why?
|
| Periodicals as Topic | 1 | 2025 | 201 | 0.770 |
Why?
|
| Awards and Prizes | 1 | 2023 | 72 | 0.760 |
Why?
|
| Pseudomonas Infections | 3 | 2023 | 122 | 0.510 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2023 | 139 | 0.280 |
Why?
|
| Biofilms | 2 | 2019 | 99 | 0.270 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 498 | 0.250 |
Why?
|
| Staphylococcus aureus | 3 | 2021 | 480 | 0.240 |
Why?
|
| Abortion, Legal | 1 | 2025 | 15 | 0.240 |
Why?
|
| Bibliometrics | 1 | 2025 | 37 | 0.230 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2024 | 11 | 0.230 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2023 | 180 | 0.220 |
Why?
|
| Staphylococcal Infections | 2 | 2021 | 573 | 0.220 |
Why?
|
| Immunoconjugates | 1 | 2024 | 46 | 0.220 |
Why?
|
| Antibodies, Monoclonal | 5 | 2022 | 1066 | 0.200 |
Why?
|
| Gastroparesis | 1 | 2023 | 66 | 0.200 |
Why?
|
| Universities | 1 | 2023 | 128 | 0.190 |
Why?
|
| Extracellular Traps | 2 | 2019 | 9 | 0.190 |
Why?
|
| Multiple Myeloma | 1 | 2024 | 205 | 0.190 |
Why?
|
| Congenital Abnormalities | 1 | 2025 | 301 | 0.190 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2021 | 44 | 0.180 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 230 | 0.180 |
Why?
|
| Sex Factors | 1 | 2025 | 1388 | 0.180 |
Why?
|
| Hemolysin Proteins | 2 | 2018 | 30 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 479 | 0.170 |
Why?
|
| Teratoma | 1 | 2021 | 131 | 0.170 |
Why?
|
| Rabbits | 4 | 2023 | 726 | 0.160 |
Why?
|
| Pneumonia | 1 | 2023 | 343 | 0.160 |
Why?
|
| Neutrophils | 2 | 2019 | 401 | 0.160 |
Why?
|
| Meningoencephalitis | 1 | 2019 | 22 | 0.150 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 399 | 0.140 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2018 | 40 | 0.140 |
Why?
|
| Implants, Experimental | 1 | 2017 | 7 | 0.140 |
Why?
|
| Bacteremia | 1 | 2021 | 429 | 0.140 |
Why?
|
| Pneumonia, Necrotizing | 1 | 2017 | 1 | 0.140 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 703 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 469 | 0.130 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 177 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 152 | 0.130 |
Why?
|
| Arthritis, Infectious | 1 | 2017 | 67 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 225 | 0.120 |
Why?
|
| Antibodies, Bacterial | 1 | 2017 | 407 | 0.120 |
Why?
|
| Osteomyelitis | 1 | 2017 | 214 | 0.110 |
Why?
|
| Cornea | 1 | 2019 | 598 | 0.110 |
Why?
|
| Wound Healing | 1 | 2018 | 489 | 0.110 |
Why?
|
| Male | 6 | 2025 | 66215 | 0.100 |
Why?
|
| Humans | 12 | 2025 | 134225 | 0.100 |
Why?
|
| United States | 3 | 2023 | 11798 | 0.100 |
Why?
|
| Female | 5 | 2025 | 72054 | 0.090 |
Why?
|
| Animals | 9 | 2023 | 36526 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2592 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 1317 | 0.060 |
Why?
|
| Hospital Charges | 1 | 2025 | 66 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 4802 | 0.060 |
Why?
|
| Retreatment | 1 | 2024 | 92 | 0.060 |
Why?
|
| Maximum Tolerated Dose | 1 | 2024 | 175 | 0.060 |
Why?
|
| Tobramycin | 1 | 2023 | 23 | 0.050 |
Why?
|
| Myenteric Plexus | 1 | 2023 | 12 | 0.050 |
Why?
|
| Maternal Deprivation | 1 | 2023 | 13 | 0.050 |
Why?
|
| Gastric Emptying | 1 | 2023 | 78 | 0.050 |
Why?
|
| Human papillomavirus 18 | 1 | 2023 | 14 | 0.050 |
Why?
|
| Financing, Organized | 1 | 2022 | 21 | 0.050 |
Why?
|
| Human papillomavirus 16 | 1 | 2023 | 99 | 0.050 |
Why?
|
| Mice | 4 | 2023 | 19049 | 0.050 |
Why?
|
| Half-Life | 1 | 2022 | 162 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 129 | 0.050 |
Why?
|
| Primates | 1 | 2022 | 87 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2022 | 129 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 4883 | 0.040 |
Why?
|
| Stomach | 1 | 2023 | 272 | 0.040 |
Why?
|
| Research Personnel | 1 | 2022 | 135 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2022 | 284 | 0.040 |
Why?
|
| Virulence | 1 | 2021 | 279 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 836 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 401 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 556 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 204 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2023 | 1041 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 153 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2021 | 187 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 830 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1392 | 0.040 |
Why?
|
| Syndrome | 1 | 2021 | 1176 | 0.040 |
Why?
|
| Staphylococcal Vaccines | 1 | 2018 | 2 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2018 | 35 | 0.040 |
Why?
|
| Titanium | 1 | 2017 | 25 | 0.030 |
Why?
|
| Financing, Government | 1 | 2017 | 31 | 0.030 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2017 | 18 | 0.030 |
Why?
|
| Ferrets | 1 | 2017 | 14 | 0.030 |
Why?
|
| Texas | 1 | 2025 | 3719 | 0.030 |
Why?
|
| Hospitalization | 1 | 2025 | 1919 | 0.030 |
Why?
|
| Monocytes | 1 | 2018 | 357 | 0.030 |
Why?
|
| Forecasting | 1 | 2017 | 377 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 1205 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2018 | 415 | 0.030 |
Why?
|
| Skin | 1 | 2018 | 545 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 710 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 7244 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2025 | 8640 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13263 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 13105 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 17591 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 21822 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 29430 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 31962 | 0.010 |
Why?
|
| Child | 1 | 2021 | 25917 | 0.010 |
Why?
|